FindTrial
Sign In

Managment of sciatica by Vatari Guggulu

An etiopathological study of vataja and vatakaphaja type of Gridhrasi and its management by vatari guggulu - GRVG

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/04/006822
Enrollment
60
Registered
2016-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Gridhrasi (Sciatica)

Interventions

Intervention1: Vatari Guggulu for Vataja Gridhrasi: Vatari Guggulu will be given in Vataja Gridhrasi patients Drug form is vati 500 mg each Dose 3 vati twice a day with warm water Duration 30 days Co

Sponsors

IPGT RA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having cardinal symptom of Gridhrasi along with positive SLR test

Exclusion criteria

Exclusion criteria: Age group less than 30 year and more than 60 year Spinal deformity Spinal tumor Traumatic acute injury to spin Congenital Spin deformity

Design outcomes

Primary

MeasureTime frame
efficacyTimepoint: 1 month—

Secondary

MeasureTime frame
safetyTimepoint: 1 month—

Countries

India

Contacts

Public ContactShalini Parashar

IPGT RA

prajapati.pradeep1@gmail.com09978403323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026